CURX
Curanex Pharmaceuticals Inc (CURX)
Healthcare • NASDAQ • $0.32+2.34%
- Symbol
- CURX
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $0.32
- Daily Change
- +2.34%
- Market Cap
- $9.15M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $9.18
- 52W Low
- $0.26
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- N/A
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
Company websiteResearch CURX on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.